771 papers
Microbiology explores the invisible world of tiny life forms that shape our health, environment, and even the air we breathe. From bacteria and viruses to fungi and parasites, this field investigates how these microscopic organisms interact with us and each other, driving everything from disease outbreaks to beneficial fermentation processes. Understanding them is crucial for developing new medicines, improving food safety, and combating global health challenges.
At Gist.Science, we make the latest discoveries in this dynamic field accessible to everyone. We process every new preprint uploaded to bioRxiv in this category, transforming dense academic findings into both clear, plain-language explanations and detailed technical summaries. This ensures that whether you are a student, a researcher, or simply curious, you can grasp the significance of cutting-edge science without getting lost in jargon.
Below are the most recent papers in microbiology, curated and summarized directly from the bioRxiv server to keep you at the forefront of discovery.
This study identifies a novel, divergent porcine adenovirus as the likely causative agent of a severe disease outbreak characterized by neonatal mortality and reproductive failure in an immunologically unexposed, high-health pig herd in New Zealand.
This study reveals that *Burkholderia multivorans* strains from chronic cystic fibrosis infections undergo convergent genetic evolution targeting global regulators to enhance survival and virulence, with the emergence of a dominant bacterial lineage serving as a stronger predictor of accelerated lung function decline than specific mutations alone.
This study identifies peptidyl protease inhibitors PFMK and EBLL as effective compounds that bind to the Cys-198 residue of the transcription factor ERM-BP, thereby blocking its DNA-binding activity and significantly suppressing *Entamoeba* encystation to prevent parasite transmission.
This study demonstrates that bacterial secreted products, particularly organic acids and peptide-like compounds from prevalent taxa like *Apilactobacillus kunkeei*, selectively inhibit non-symbiotic and pathogenic fungi while permitting beneficial yeast symbionts to persist in the stingless bee larval diet, thereby playing a crucial role in structuring the host microbiome.
This study demonstrates that insertions and deletions in multiple classes of simple sequence repeats, including both frameshifting homopolymer tracts and in-frame triplet repeats, alter protein function and directly contribute to drug susceptibility variations in *Mycobacterium tuberculosis*.
This study reports the discovery and structure-activity relationship optimization of a novel Rv1625c/Cya agonist chemotype, yielding lead compound 25 with potent antitubercular activity and oral bioavailability, despite observed pharmacokinetic limitations in a related analog.
This study reveals that a cis-encoded RNA-RNA interaction within the *yabJ-spoVG* operon in *Staphylococcus aureus* creates an RNase III substrate that represses SpoVG expression, thereby modulating biofilm formation, cell wall thickness, and susceptibility to antimicrobials.
This study characterizes IME1, a novel lineage of double-stranded, likely filamentous viruses abundant in *Dehalococcoides*-containing mixed cultures, which are distinguished by their unique protein composition resembling filamentous bacterial and budding archaeal viruses rather than typical tailed phages.
This paper characterizes TSR1, a unique self-limiting dimeric TIR effector in type III CRISPR immunity that activates NAD+ degradation upon binding viral cA3 signals and subsequently auto-inactivates via its integrated Crn4 ring nuclease domain.
This study demonstrates that engineering *Pseudomonas aeruginosa* hosts (specifically viPAO1) by sequentially removing intracellular defense systems and prophages significantly expands recoverable phage diversity, enabling the isolation of a broad collection of novel temperate phages that are otherwise inaccessible due to host genetic barriers.